Travere Therapeutics TVTX
NASDAQ TVTX
$56.93 +0.08 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Change in Accured Expenses (2011 - 2026)

Updated

Travere Therapeutics' Change in Accured Expenses was $3.69 million in Q2 2026, up 175.7% from $1.34 million a year earlier.

Analysis

Travere Therapeutics (TVTX) Change in Accured Expenses (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Travere Therapeutics' Change in Accured Expenses was $19.83 million through Jun 30, 2026, up 937.6% year-over-year; for FY2025, it was $28.84 million.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 45.5% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was -$31.06 million in FY2024, $24.76 million in FY2023 (+11.6%), $22.18 million in FY2022 (+33.0%) and $16.68 million in FY2021 (+277.6%).
  • Quarterly Change in Accured Expenses has moved between -$24.84 million (Q1 2024) and $19.7 million (Q3 2025) over five years.
  • Compared with a year earlier, Change in Accured Expenses was higher in three of the last five quarters, with growth averaging 177.8%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q3 2025 (growth of 728.5%); the worst was Q2 2023 (a decline of 88.5%).
  • Per Business Quant data, TVTX's Change in Accured Expenses in the three quarters before Q2 2026 was -$20.9 million (Q1 2026), $17.34 million (Q4 2025) and $19.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Travere Therapeutics 5.36 Bn 4.96 Bn 167.41 Mn 3.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.69 Mn
Mar 31, 2026 -20.90 Mn
Dec 31, 2025 17.34 Mn
Sep 30, 2025 19.70 Mn
Jun 30, 2025 1.34 Mn
Mar 31, 2025 -9.54 Mn
Dec 31, 2024 7.73 Mn
Sep 30, 2024 2.38 Mn
Jun 30, 2024 -16.33 Mn
Mar 31, 2024 -24.84 Mn
Dec 31, 2023 17.30 Mn
Sep 30, 2023 14.77 Mn
Jun 30, 2023 1.57 Mn
Mar 31, 2023 -8.88 Mn
Dec 31, 2022 6.17 Mn
Sep 30, 2022 6.94 Mn
Jun 30, 2022 13.68 Mn
Mar 31, 2022 -4.61 Mn
Dec 31, 2021 10.45 Mn
Sep 30, 2021 920,000.00
API Access

Travere Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=TVTX&period=max&api_key=YOUR_API_KEY